"Topline results that showed a 60% higher probability of improvement in clinical status compared to placebo, as well as a more than 50% reduction in the risk of death or respiratory failure were reported by OncoImmune in September."

I'm confused, are they saying that they did not hit their p value because there is only 60% confidence versus the 95% confidence (p=.05) normally required for statistical significance?